571 documents showing 1–60

Apr 16, 2026

Grizzly Research

Sinch AB SINCH

Sinch's golden-goose subsidiary Inteliquent enables ~45% of US imposter robocalls; with state AGs closing in and zero disclosure, the market is materially mispricing regulatory downside.

N4 V3

Apr 01, 2026

Land & Buildings

Welltower Inc. WELL

Welltower's 10-year executive program could pay CEO Mitra up to $3 billion while incentivizing dilutive growth at a 144% NAV premium — shareholders should sell WELL and rotate into Ventas or AHR.

N5 V4

Apr 01, 2026

Land & Buildings

Multiple REITs (21 underperformers)

Land & Buildings names 21 REIT CEOs who trail their own proxy peers on 1-, 3-, and 5-year TSR yet collect multi-million packages — shareholders should vote against say-on-pay and the comp committees.

N3 V3

Mar 30, 2026

Muddy Waters

SoFi Technologies SOFI

SOFI booked a $312M JPMorgan borrowing as a loan sale, inflating ~$1B of EBITDA and enriching management while shareholders absorb ~15% annual dilution.

N4 V3

Mar 25, 2026

Spruce Point Capital

Bunge Global SA BG

Bunge is a levered agribusiness roll-up masking a failing Viterra deal with opaque accounting; strip out the hand-waving and the stock is worth $24-$55, 55-80% below $124.

N5 V4

Mar 22, 2026

Muddy Waters

SoFi Technologies SOFI

SOFI's silence on 11 specific accounting questions confirms Muddy Waters' view that 2025 Adjusted EBITDA is inflated ~90% via mislabeled financings, hidden debt, and misstated risk retention.

N4 V2

Mar 19, 2026

Grizzly Research

Accor SA AC

Accor markets itself as an anti-trafficking leader, yet 80% of its hotels accepted Grizzly's red-flagged bookings for underage girls and CEO Bazin allegedly sits in Epstein's orbit.

N4 V3

Mar 17, 2026

Muddy Waters

SoFi Technologies, Inc. SOFI

SoFi's $1,054M reported 2025 EBITDA is ~90% inflated via manipulated charge-off rates, off-balance-sheet VIEs and subsidized seller-financed sales that feed CEO Noto's comp — real EBITDA is ~$103M.

N5 V3

Feb 20, 2026

Spruce Point Capital

Nova Minerals Limited NVA

Nova Minerals' 'Qualified Person' geologist can't be verified to have graduated, management ties to market-manipulation figures, and shares trade at 48.7x resources vs 18.8x peer median — 45-60% downside, up to 100%.

N4 V3

Feb 17, 2026

Starboard Value

Tripadvisor, Inc. TRIP

Tripadvisor's Board has tolerated ~50% value destruction under CEO Goldberg; Starboard demands a sale of the entire company or will run a majority-slate proxy fight at the 2026 meeting.

N4 V2

Feb 12, 2026

Spruce Point Capital

Super Group (SGHC) Limited SGHC

Super Group overstates EBITDA by consolidating 100% of South African crown-jewel Raging River despite evidence of a 10.71% minority interest, implying 20%-50% downside to $4.25-$6.80.

N4 V3

Feb 06, 2026

Grizzly Research

Electro Optic Systems Holdings Limited EOS.AX

EOS's stock-doubling US$80m Korean defense contract is with Goldrone, a defunct three-person agricultural drone company — a fake catalyst used by a desperate management to pump a failing stock.

N4 V3

Feb 04, 2026

Wolfpack Research

IonQ Inc IONQ

IONQ's $14B valuation relied on Pentagon 'validation' that was really backdoor congressional earmarks — now unfunded — with management hiding the $54M hole via non-quantum roll-ups while insiders dumped $396M.

N4 V2

Jan 27, 2026

Spruce Point Capital

Resideo Technologies, Inc. REZI

Resideo is an over-levered, serially-disappointing Honeywell spin whose split-up is a 'trust me' distraction from $2bn of troubled M&A and -37% cash-flow decline; 25-50% downside.

N4 V3

Jan 27, 2026

Elliott Management

Toyota Industries Corporation 6201.T

Toyota Real Estate's ¥18,800 TOB undervalues Toyota Industries by 39% versus NAV and 85% on core business; shareholders should refuse to tender and pursue a standalone plan instead.

N5 V4

Jan 27, 2026

Elliott Management

Toyota Industries Corporation 6201

Toyota Industries' ¥18,800 take-private undervalues the company by 39%; shareholders should reject the tender and pursue a Standalone Plan worth >¥40,000 per share.

N5 V4

Jan 18, 2026

Elliott Management

Toyota Industries Corporation 6201

Toyota Industries' ¥18,800 take-private undervalues NAV ¥26,134 by 40%; rejecting the TOB and executing Elliott's Standalone Plan unlocks >¥40,000 per share by 2028.

N4 V3

Jan 18, 2026

Elliott Management

Toyota Industries Corporation 6201

Toyota Fudosan's ¥18,800 squeeze-out of Toyota Industries undervalues NAV by ~40%; reject the TOB and back Elliott's Standalone Plan targeting >¥40,000 per share by 2028.

N5 V4

Dec 04, 2025

Grizzly Research

Trustpilot Group PLC TRST

Trustpilot runs a mafia-style extortion racket — seeding hyper-negative profiles to force businesses to pay, while tolerating fake reviews; impending Google de-ranking will destroy its business model.

N4 V3

Dec 01, 2025

Engine Capital

UniFirst Corporation UNF

Engine urges UniFirst's independent directors to form a special committee and force a sale — the Croatti family's rejection of four Cintas bids has already cost shareholders ~$1.3B.

N4 V2

Nov 25, 2025

Engine Capital

UniFirst Corporation UNF

UniFirst is stagnating under Croatti trustee stewardship that rejected a premium Cintas bid; Engine demands a sale, board refresh, and fair proxy process to unlock value.

N4 V1

Nov 12, 2025

Spruce Point Capital

IperionX Ltd. IPX

Spruce Point shorts IperionX: its 'revolutionary' HAMR titanium process is unlikely to displace 70-year Kroll, customers are absent, and the $1.2bn market cap implies 70-95% downside risk.

N4 V3

Nov 06, 2025

Grizzly Research

HelloFresh SE HFG

HelloFresh's core meal-kit business is in terminal decline while CEO Dominik Richter pledges 77% of his stock to fund his brother's leveraged real-estate empire — a margin call could crater the stock.

N4 V3

Nov 06, 2025

Grizzly Research

HelloFresh SE HFG

HelloFresh's CEO has pledged 77% of his shares to fund brother's real estate, driving an EUR100m buyback to avert margin calls while the meal-kit business structurally collapses.

N5 V3

Oct 31, 2025

Wolfpack Research

Datavault AI Inc. DVLT

DVLT is a buzzword-stuffed pump-and-dump: CEO sanctioned by the SEC, co-patenting with a convicted felon, and the 'AI platform' is NFTs of Putin vomiting.

N4 V2

Oct 08, 2025

Wolfpack Research

Datasection, Inc. 3905.TYO

Datasection is a front smuggling restricted NVIDIA B200 GPUs to blacklisted Tencent via shell entities and Chinese-linked financing; forced regulatory decoupling will destroy the business.

N4 V2

Oct 08, 2025

Wolfpack Research

Datasection Inc. 3905

Datasection is covertly supplying 15,000 export-controlled NVIDIA B200 GPUs to sanctioned Chinese military-linked Tencent via CEO-founded shell NowNaw Japan; already reported to US BIS and Japanese authorities.

N4 V2

Sep 18, 2025

Spruce Point Capital

Uranium Energy Corp UEC

Spruce Point calls UEC a promotional penny-stock-turned-$5bn uranium speculator: CEO Adnani's ties to charged fraudsters plus zero proven reserves imply 65-85% downside.

N4 V3

Sep 11, 2025

Wolfpack Research

Faraday Future Intelligent Electric Inc. FFAI

Wolfpack is short FFAI: Jia Yueting pumped the stock with fake preorders, a rebadged Chinese minivan, and shell-company financing while hiding Lucid shares from bankruptcy — SEC and DOJ are circling.

N4 V2

Sep 01, 2025

Kerrisdale Capital

Pure Storage, Inc. PSTG

Pure Storage's hyperscaler dream is hype: HDDs dominate at 5-6x TCO advantage, the Meta deal is replicable, and Pure deserves a peer multiple, implying ~55% downside to $35.

N4 V3

Aug 27, 2025

Grizzly Research

Archer Aviation Inc ACHR

Archer Aviation is 'the Nikola of the skies' — the Midnight eVTOL is uncertifiable, the Covington factory sits idle, and the $6B order book is built on shell companies and cancelled deals.

N4 V3

Aug 21, 2025

Scorpion Capital

Soleno Therapeutics SLNO

Scorpion petitions FDA to recall Soleno's VYKAT XR after 7 hospitalizations for fluid overload/potential heart failure in children and alleged safety-data manipulation invalidate the drug's risk-benefit.

N4 V1

Aug 18, 2025

Spruce Point Capital

iRhythm Technologies, Inc. IRTC

Spruce Point argues iRhythm hid FDA-flagged Zio AT defects that killed patients and faces a DOJ cover-up probe; commoditized tech and an overstated asymptomatic market imply 40-70% downside.

N4 V3

Aug 15, 2025

Scorpion Capital

Soleno Therapeutics SLNO

Scorpion shorts Soleno (SLNO), arguing VYKAT XR — a $500K/year repackaged 50-year-old generic — is causing pediatric heart-failure hospitalizations and was approved on sham trial data; the launch will collapse.

N4 V2

Aug 11, 2025

Engine Capital

Avantor, Inc. AVTR

Avantor's board has presided over five years of self-inflicted operational and capital-allocation failures; a refreshed board, cost discipline, buybacks and portfolio optimization can deliver 97-134% upside by 2027.

N4 V3

Jul 22, 2025

Spruce Point Capital

Limbach Holdings, Inc. LMB

Limbach's ODR recurring-revenue story masks decelerating organic growth, aggressive accounting, and fraud-linked directors; at 18x FY26E EBITDA we see 20-50% downside to $62-99/share.

N4 V3

Jun 25, 2025

Wolfpack Research

CTO Realty Growth, Inc. CTO

CTO Realty's management inflates AFFO by excluding recurring capex, used a sham loan to hide a tenant collapse, and is diluting shareholders 70% to fund a dividend it cannot cover.

N4 V2

Jun 17, 2025

Land & Buildings

National Healthcare Corporation NHC

NHC's below-market 1991 lease with NHI expires 2026; renegotiation will cut NHC EBITDA 19-38% — L&B is short NHC.

N3 V2

Jun 01, 2025

Land & Buildings

US REIT sector (15 underperforming large-cap REITs)

15 large-cap REITs persistently underperformed their proxy peers over 1-, 3- and 5-year periods yet kept paying CEOs the same — shareholders should vote against comp committees and say-on-pay.

N3 V3

May 28, 2025

Spruce Point Capital

Tempus AI, Inc. TEM

Tempus AI is an AI-branded diagnostics roll-up whose tiny AI revenue, Lefkofsky-linked restatement history, and round-tripped related-party deals imply 50-60% downside to ~$25-34/share.

N5 V3

May 16, 2025

Ancora

Forward Air Corporation FWRD

Ancora urges FWRD shareholders to vote AGAINST Chair Mayes, Polit, and Tucker — the directors behind the disastrous 2023 Omni acquisition that destroyed ~80% of equity value — to force an expedited sale.

N4 V4

May 16, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 has trailed Valero and Marathon by 138-188% over a decade while paying its CEOs $140M; Elliott's four nominees will simplify the conglomerate and unlock 75%+ upside.

N4 V4

May 15, 2025

Elliott Management

Phillips 66 PSX

Phillips 66's conglomerate structure masks value; electing Elliott's four nominees to execute the Streamline 66 plan and fix governance lifts shares from $103 to $180+ (75% upside).

N4 V4

May 14, 2025

Elliott Management

Phillips 66 PSX

Both top proxy advisors (ISS and Glass Lewis) back Elliott's Streamline 66 campaign, endorsing all four dissident nominees to fix Phillips 66's CEO-driven underperformance by the May 21 vote.

N2 V3

May 13, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 is underperforming under a board that obfuscates results; elect Elliott's four nominees on the GOLD card to replicate the Marathon playbook and unlock value.

N2 V3

May 12, 2025

Carl Icahn

Phillips 66 PSX

Phillips 66's refining-plus-midstream conglomerate trades at a 6.1x discount to an 8.1x SOTP; breaking it up and replacing complacent directors unlocks ~75% upside to $183.

N5 V4

May 09, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 is deeply undervalued under a conflicted, overpaid leadership team; electing Elliott's four directors and adopting the Streamline 66 portfolio-simplification plan could unlock 75%+ upside.

N4 V4

May 08, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 has underperformed Marathon and Valero for years while CEO Mark Lashier collected $79M; elect four Elliott nominees to break up the conglomerate and restore accountability.

N4 V4

May 07, 2025

Muddy Waters

AppLovin Corporation APP

Muddy Waters is short AppLovin; the CEO and CTO's March 2025 denials of persistent identifiers are demonstrably false, exposing APP to deplatforming, regulatory, and margin-compression risks.

N4 V3

May 07, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 shares jumped 11% on Elliott's Streamline 66 plan and sank when the board defended its conglomerate; vote for change to unlock value.

N3 V4

May 06, 2025

Carl Icahn

Phillips 66 PSX

Phillips 66 has underperformed Marathon by 511% under a complacent board; electing Elliott's four nominees and spinning Midstream/CPChem/JET unlocks ~75% upside ($103 → $183).

N5 V4

May 06, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 is a conglomerate trading at a refiner multiple; replace four directors, spin Midstream/CPChem/JET, and buy back 80% of shares for ~75% upside to $183.

N5 V4

May 05, 2025

Wolfpack Research

UFP Technologies, Inc. UFPT

UFPT's largest customer Intuitive Surgical — 96.5% of 2024 organic growth — is quietly insourcing drapes and buying from rival Microtek while insiders dumped $51M in stock.

N4 V2

May 03, 2025

White Diamond Research

ZJK Industrial ZJK

ZJK is a Chinese nuts-and-bolts maker fabricating a Nvidia AI partnership to pump its US-listed stock before pre-IPO insiders dump 60M shares (cost basis 7c) at the 3/31/25 lock-up expiry.

N4 V2

May 03, 2025

White Diamond Research

Pulse Biosciences PLSE

PLSE's pivot to benign thyroid ablation repeats its failed dermatology playbook — tiny market, weak clinical data, revolving-door CEOs — and will trigger another stock collapse.

N3 V3

May 01, 2025

Elliott Management

Phillips 66 PSX

Phillips 66 has squandered value through a failed midstream pivot and a captured board; electing Elliott's four nominees and separating midstream unlocks ~$40B+ of trapped value.

N5 V4

May 01, 2025

Elliott Management

Phillips 66 PSX

Phillips 66's dilutive midstream pivot has destroyed TSR versus refining peers; a midstream spin and refreshed governance — as at Marathon and Suncor — can unlock the buried value.

N4 V4

May 01, 2025

Elliott Management

Phillips 66 PSX

Phillips 66's board has been captured by CEO-Chairman Mark Lashier; electing Elliott's four Gold Card nominees will restore independence and unlock value at this peer-lagging refiner.

N4 V3

Apr 30, 2025

Spruce Point Capital

Clear Secure, Inc. YOU

Spruce Point is short Clear Secure (YOU): TSA Digital ID and weakening airline partnerships are eroding CLEAR's value prop while accounting red flags and a CAO from Ubiquiti suggest 30-50% downside.

N4 V3

Apr 30, 2025

Elliott Management

Phillips 66 PSX

Phillips 66's conglomerate structure traps midstream value and operational performance; replace four directors and separate midstream to close the gap with MPC and VLO peers.

N2 V3